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Abstract Purpose: Our objective
was to assess whether SpO2/FiO2
(SF) ratio could be a useful NIV
outcome predictor in children with
acute respiratory failure (ARF) and
tried to develop a predictive model of
NIV failure.
Methods: Prospective, observa-
tional, multicenter study. Episodes of
ARF-fulfilling inclusion criteria from
15 January 2010 to 14 January 2011
were treated with NIV according to a
pre-established protocol. Clinical
variables were collected at baseline
and at 1, 2, 6, 12 and 24 h. Failure
criterion was the need for endotra-
cheal intubation. Failures were
considered as ‘‘early’’ if occurring
B6 h after NIV initiation, ‘‘interme-
diate’’ if occurring between 6 and
24 h, and ‘‘late’’ if occurring after
24 h. Variables with a p \ 0.1 in
univariate analysis corrected by age
were included in multivariate analy-
sis. Models were calculated based on
multivariate analysis.
Results: During the study period,
390 episodes were included. NIV
success rate was 81.3 %. Among
ARF causes, failure occurred most
frequently in ARDS episodes. The
failure predictive model for the whole
sample included SF ratio at 1 h, age
and PRISM III-24 (area under the
curve AUC of 0.755). For early NIV
failures, SF ratio at 1 h was the only
variable within model (AUC 0.748).
The analysis of intermediate NIV
failures identified 3 variables inde-
pendently linked to NIV outcome:
PRISM III-24, RR decrease at 6 h,
and SF ratio at 6 h (AUC 0.895). No
model was identified for late NIV
failure.
Conclusions: SF ratio is a reliable
predictor of early NIV failure in
children.
Keywords Non invasive positive-
pressure ventilation 
Acute respiratory failure 
Clinical markers  Hypoxemia 
Mechanical ventilation  Pediatrics
Introduction
Noninvasive ventilation (NIV) is nowadays a basic
respiratory support tool in adult patients and it is
increasingly being used in children. Clinical experience
and some randomized controlled studies in pediatric
patients have shown the beneficial effects of NIV in
selected patients [1, 2]. Failure of NIV and the consequent
‘‘delayed’’ intubation could increase patient’s morbidity
and mortality, as suggested in adult studies [3]. Therefore,
the availability of early predictors of NIV failure could be
very helpful to physicians and have an impact in terms of
patient safety. As a result, some studies have tried to
identify predictors of pediatric NIV failure [4–9].
Several pediatric studies reported the association of
hypoxemic acute respiratory failure (ARF), acute respi-
ratory distress syndrome (ARDS) and high oxygen
requirements with NIV failure [4–6, 8, 10, 11]. Similarly,
adult studies showed that ARDS diagnosis and severe
hypoxemia was linked to NIV failure [12–14]. Further-
more, PaO2/FiO2 (PF) ratio has been identified as an
outcome predictor of NIV in hypoxemic adults [14].
Transcutaneous oxygen hemoglobin saturation
(SpO2)/FiO2 (SF) ratio is a non-invasive, easily and
continuously available figure that has been shown to be a
reliable marker for PF ratio [16–18]. According to this, a
low SF ratio would correspond to a severe hypoxemic
ARF. Furthermore, Spada et al. [19] found SF ratio to be
useful for identifying NIV failure in adult patients.
Considering that PF ratio may predict NIV outcome
and that SF ratio correlates well with PF ratio, our
hypothesis was that such an objective, noninvasive and
continuous variable could help predict NIV outcome. In
addition, we also sought to develop a predictive model for
NIV outcomes.
Methods
A multiple-center prospective observational study was
conducted in ten Spanish and two Portuguese pediatric
intensive care units (PICUs). Median time performing
NIV in the participating PICUs was 6.5 years (inter-
quartile range 3.5–11.5). Four PICUs had performed NIV
in 90–150 episodes, three PICUs in 150–500 cases, and
five PICUs in more than 500 episodes. The study period
was between 15 January 2010 and 14 January 14th. This
research project was approved by the Research Ethics
Committee of the Hospital Universitario Central de
Asturias, with a waiver of written consent.
Inclusion criteria
Children with ARF or acute-on-chronic respiratory failure
without improvement despite medical treatment and:
• severe dyspnea at rest (modified Wood’s Clinical
Asthma Score C5 in asthma or bronchiolitis) [20], or
• a respiratory rate (RR) above two standard deviations
(SD) for child’s age normal range [21], or
• venous PCO2 [ 55 mmHg or arterial PCO2 [50 mmHg,
or
• PF ratio under 250 and above 100 (above 150 if ARDS
was suspected).
Exclusion criteria
Uncorrected cyanotic congenital heart disease, palliative
use of NIV (do-not-intubate patients), ARDS with a PF
ratio B150, unreliable SpO2 readings (for example,
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capillary refill time [3 s), contraindication to NIV, and
previous invasive ventilation during the same PICU
admission. Patients in whom heliox was used during NIV
were also excluded.
We considered contraindications to NIV support any
of the following: cardiorespiratory arrest, hemodynamic
instability despite fluid load and vasoactive treatment
([10 lg/kg/min of dopamine), severe arrhythmia,
Glasgow coma scale score \10, facial trauma or sur-
gery, facial deformity (if helmet not available), vocal
cords paralysis, undrained pneumothorax, need for
endotracheal intubation to manage secretions or airway
protection or active upper gastrointestinal tract
bleeding.
Intubation criteria
NIV was withdrawn and patients were intubated when
SpO2 was below 85 % or venous PCO2 above 65 mmHg or
dyspnea worsened despite maximal NIV setting, or if any
of the exclusion criteria appeared. Maximal NIV settings
were considered as inspiratory positive airway pressure
(IPAP) C25 cmH2O, or continuous positive airway pres-
sure (CPAP) or expiratory positive airway pressure
(EPAP) C12 cmH2O, with FiO2 1.
NIV strategy
CPAP or bilevel NIV were delivered using a nasal mask,
face mask, full-face mask, nasopharyngeal tube, nasal
prongs or helmet device. Following the Respiratory
Group of the Spanish Society of Pediatric Intensive Care
guidelines [22], CPAP or EPAP initial ventilator setting
was 5 cmH2O. IPAP was started at 6–8 cmH2O to
achieve tolerance and patient-ventilator synchrony. It
was suggested that FiO2 should be as low as possible in
order to maintain SpO2 between 93 and 98 %. Sedation
was administered, if required, at the discretion of the
physician in charge according to each PICU sedation
protocol.
Monitoring
All patients were continuously monitored by means of
electrocardiography, pulse oximeter and RR. Masimo
pulse oximeters (Masimo Corporation, Irvine, CA) were
used in four PICUs, Philips (Philips Healthcare, Eind-
hoven, Nederlands) in four, Ohmeda (GE Healthcare,
United Kingdom) in two, and different types of pulse
oximeters in two PICUs. Blood gas analysis was only
performed when considered necessary by the attending
physician.
Data collection
Patients with multiple NIV episodes were considered
individually, since each episode requiring NIV presents
new variables potentially affecting outcome. For each
episode, the following variables were collected: age,
gender, weight, ARF cause, underlying disease, paediatric
risk of mortality (PRISM) III score within the first 24 h of
PICU admission (PRISM III-24) [23], NIV duration
(hours), NIV outcome, and mortality. Clinical data col-
lected were RR, heart rate (HR), SpO2 and FiO2 before
NIV was started. Initial FiO2 values were estimated based
on the following equivalences: Nasal cannulae with
oxygen flow rate of 1, 2, 3 and 4 lpm: FiO2 24, 28, 32 and
36 %, respectively; aerosol mask with oxygen flow rate of
8 lpm: FiO2 40 %; Venturi mask: FiO2 from 24 to 50 %;
nonrebreathing mask with reservoir bag: FiO2 100 %. The
same data as well as CPAP, EPAP and IPAP values were
collected at 1, 2, 6, 12 and 24 h. RR, RR variation, HR,
HR variation, and SpO2 were registered when figures
remained stable for at least 2 min.
Statistical analysis
The sample was described using either mean ±SD or
median (interquartile range). Relative and absolute fre-
quencies were used in order to describe categorical
variables. The Nelson–Aalen estimator was used to esti-
mate the incidence curve for NIV success and failure
along the study. We analysed the sample as a whole and
then made three subgroups according to the duration of
NIV before failure occurred: less than 6 h (‘‘early’’ fail-
ure), 6–24 h (‘‘intermediate’’ failure) and more than 24 h
(‘‘late’’ failure). SpO2 values C98 % were not included in
statistical analysis because SpO2–PaO2 correlation is lost
above this value [18]. Variables with p\0.1 in univariate
analysis (avoiding colinearity) were included in a forward
stepwise fashion based on the likelihood ratio multivariate
analysis. Venous PCO2 was excluded due to the scarcity of
these values. Age was included in multivariate analysis to
control statistical confusion due to this variable. Receiver
operator characteristic (ROC) curves were used to find
cutoff values of the predictive models obtained. As usual,
the area under ROC curve (AUC) was used as a measure
of the predictive capacity. A value of P \ 0.05 was
considered statistically significant.
Results
During the 12-month study, the total number of NIV
episodes included was 390, in 369 patients. The main
cause for ARF was acute bronchiolitis, which accounted
for 42 % of the cases. Other frequent ARF causes were
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pneumonia and bronchospasm (Fig. 1). More than half of
the episodes occurred in previously healthy children. The
most frequent underlying conditions were cardiopathy
and prematurity (Table 1 shows demographic data of the
episodes included). Among children who were admitted
to the PICU and received NIV more than once (N = 15),
the median number of episodes was two (interquartile
range 2–3). Only two of them did not have any underlying
condition, while the remaining 13 had different diagnosis:
cardiopathy (2), prematurity (2), cerebral palsy (2), neu-
romuscular disease (1), bronchopulmonary dysplasia (1),
and ‘‘others’’ (5).
One hundred and twenty-four episodes (31.3 %) were
managed initially with CPAP. Twenty-eight of these 124
episodes (22.6 %) were switched to two levels of pressure
NIV because of increasing respiratory distress despite
CPAP. The remainder (166 episodes) was treated from the
start with two levels of pressure NIV. Sedatives were used
in 49.2 % of the cases; midazolam was the most frequent
drug employed. None of the failed episodes were con-
sidered to be related to the use of sedatives.
The overall success rate was 81.3 % (Fig. 1). A total
of 15 deaths occurred (3.8 %); none of them were con-
sidered to be related to NIV use, according to the opinion
of the physicians in charge. Six of them occurred in the
success group, due to progressing underlying conditions
(not related to ARF). The other nine deaths were due to
progressing underlying diseases, therapeutic effort with-
drawal (2), and pulmonary hemorrhage and multiorgan
failure in one case each.
Similar intubation rates were observed for all ARF
causes except for ARDS, which accounted for five out of
ten cases requiring invasive ventilation (p = 0.010). Mean
NIV duration in ARDS-diagnosed patients who were
eventually intubated was 16 ± 7.5 h. One of the ARDS
cases successfully treated with NIV eventually died (due
to the underlying condition), whereas four out of five
ARDS episodes that were intubated, eventually died.
Failure analysis
Table 2 shows the main demographic and baseline char-
acteristics of success and failure groups. When
considering the whole sample, the only variables inde-
pendently linked to NIV failure were SF ratio at 1 h (10
units) (odds ratio, OR 0.942, confidence interval, CI 95 %
0.880–1.008; p = 0.086), age (OR 0.970, CI 95 % 0.951–
0.990; p = 0.003), and PRISM III-24 score (OR 1.232, CI
95 % 1.085–1.398; p = 0.001). The predictive model is
shown in Table 3. Fig. 2 shows the Kaplan–Meier curve
of the probability of avoiding intubation during the first
72 h using the cutoff value obtained with this predictive
model. On the collected data, the behaviour of the
Fig. 1 Flowchart representing the outcome of the 390 NIV
episodes and the different acute respiratory failure causes, with
the corresponding NIV failure rates. ARF acute respiratory failure,
NIV non-invasive ventilation, ARDS acute respiratory distress
syndrome, CPE cardiogenic pulmonary edema, UARI, upper airway
respiratory infection (in chronic conditions). Note the high failure
rate of ARDS episodes (statistically significant)
1098
children not included in multivariate analysis due to
missing data did not show any statistically significant
difference with the included ones (data not shown).
NIV failures occurred in the first 6 h in 27 cases,
between 6 and 24 h in 26 episodes, and after 24 h in the
remaining 20 cases (Fig. 1).
Episodes failing before 6 h
Multivariate analysis identified SF ratio at 1 h (OR 0.986,
CI 95 % 0.974–0.997; p = 0.018) as the only variable
independently linked to early NIV failure. The optimal
cutoff value suggested to detect early NIV failures was
193. The predictive model is shown in Table 3.
Episodes failing between 6 and 24 h
Multivariate analysis identified PRISM III-24 (OR 1.224,
CI 95 % 1.110–1.349; p \ 0.001), RR decrease at 6 h
(OR 0.929, CI 95 % 0.892–0.968; p \ 0.001), and SF
ratio at 6 h (10 units) (OR 0.923, CI 95 % 0.857–0.994;
p = 0.035), as independent predictors of NIV failure
between 6 and 24 h. The predictive model is shown in
Table 3.
Episodes failing after 24 h
We found significant differences in SF ratio at 24 h
(p = 0.029) and FiO2 at 24 h (p = 0.032). No variable
was identified as independent predictor of late NIV
failure.
Discussion
An important and controversial issue related to NIV in
children is the early prediction and identification of NIV
failure. Consequently, the availability of any easily
obtained, noninvasive, and reliable clues or markers
would be very helpful to physicians. To our knowledge,
the present study is the largest one focusing on pediatric
NIV and the first which assesses SF ratio as an early
outcome marker. Considering the challenges of placing
arterial catheters in small children, coupled with the
stress for the child, which will likely increase respiratory
effort and oxygen consumption, noninvasive measure-
ments are more suitable for this population. Performance
of blood gas analysis has been reported to be quite
infrequent in previous studies [6]. Furthermore, we sug-
gest three predictive models for NIV failure, showing
acceptable AUC (Table 3). It should be noted the low
positive predictive values, with very high negative pre-
dictive values in all three models. This is explained
because the cutoff values have been chosen in an intent
of not excluding any child at risk of failing the NIV trial.
The low NIV failure rate also contributed to the low
positive predictive values.
The major advantage of SF ratio is that it can be
continuously monitored in a noninvasive manner. Spada
et al. [19] reported that SF ratio during NIV could be
useful to make clinical decisions in adult patients suf-
fering from ARF with no underlying malignancy . Our
data show that SF ratio might be useful to detect NIV
failure throughout NIV delivery, especially in the first
Table 1 Demographic and main baseline characteristics of the
episodes; included data are expressed as median (interquartile
range), or number (%)
Whole sample
(N = 390)
Patients’ characteristics
Age (months) 6.6 (1.5–26.5)
Males (%) 59
Weight (kg) 7 (4.2–12)
Intubations 73 (18.8 %)
Deaths 15 (3.8 %)
PRISM III score 3 (0–5)
HR (beats/min) 160 (140–180)
RR (breaths/min) 48 (36–60)
FiO2 (%) 40 (28–74.5)
SpO2 96 (93–99)
Venous PCO2 (mmHg) 55.9 (45–66)
SF ratioa 261.1 (155.7–356.7)
Venous pH 7.31 (7.25–7.37)
Venous lactate (mmol/l) 1.7 (1.2–2.4)
ARF cause—number (%) Intubation
rate (%)
Pneumonia 65 (16.6) 17.2
Bronchiolitis 164 (42.1) 17.1
Bronchospasm 53 (13.6) 18.9
ARDS 10 (2.5) 50
Cardiogenic pulmonary edema 16 (4.1) 6.3
Laryngitis 7 (1.8) 28.6
Upper airway respiratory infection 36 (9.3) 16.7
Others 39 (10) 25
Underlying disease—number (%)
None 213 (54.7) 15.6
Cardiopathy 28 (7.1) 17.9
Prematurity 21 (5.4) 38.1
Cerebral palsy 19 (4.9) 5.3
NMD 18 (4.6) 11.8
Bronchopulmonary dysplasia 13 (3.3) 23.1
Immunodeficiency 13 (3.3) 30.8
Sepsis 3 (0.8) 66.7
Restrictive pulmonary disease 2 (0.5) 100
Others 60 (15.4) 22
PRISM III-24 was calculated within the first day of PICU
admission
ARF acute respiratory failure, HR heart rate, RR respiratory rate,
PRISM pediatric risk of mortality, ARDS acute respiratory distress
syndrome, NMD neuromuscular disease
 P value \0.05 compared with the rest of ARF causes
a SpO2 over 97 % were excluded to calculate SF ratio
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hours of noninvasive respiratory support, as suggested by
SF ratio inclusion in all our three models for NIV out-
come prediction (Table 3).
The optimal cutoff value suggested to detect early
NIV failures was 193 (SF ratio at 1 h, Table 3). This
would correspond to a PF ratio of 188 or 155 according to
Khemani’s equations [16, 18], which are similar to the
values reported by Antonelli [13, 14]. Thus, if a hypox-
emic patient is not able to achieve an SF ratio of around
190 or higher after 1 h of NIV, endotracheal intubation
should be duly considered.
It should be noted that SF ratio has been demonstrated
to be a reliable surrogate for PF ratio as long as SpO2 is
between 80 and 97 % [18]. When SpO2 is over 97 %, the
oxyhemoglobin dissociation curve flattens and the SF ratio
reliability is lost, potentially leading to inadvertent hy-
peroxygenation. Therefore, we believe that a target SpO2
between 92 and 97 % in NIV-treated patients should be
established. Using SF ratio might help detect worsening
hypoxemia early and patients receiving NIV who are
prone to failing and also avoid potential oxygen toxicity.
We found a high intubation rate in ARDS (50 %),
when compared to other ARF causes. However, ARDS
diagnosis was not included in any predictive model of
failure, which might be related to the low number of
ARDS episodes included in our study (n = 10). ARDS
had already been identified as a major risk factor for NIV
failure in pediatric and adult patients [12, 13]. Conse-
quently, hypoxemic patients who are at risk of developing
ARDS should be monitored very closely. Invasive ven-
tilation remains the gold standard therapy in ARDS;
therefore, it should not be delayed when necessary as this
could worsen the outcome and compromise patient safety.
Lack of NIV effectiveness in ARDS may be related to the
transient losses of EPAP (equivalent to positive end-
expiratory pressure during invasive ventilation) due to the
inevitable air leakage. This may produce lung derecruit-
ment, which would impair gas exchange [24]. Of note,
mean duration of NIV in ARDS episodes that required
intubation was 16 h. This highlights the importance of
monitoring these patients very closely, and not just in the
first hours of admission. Furthermore, the high rate of
Table 2 Demographic and baseline characteristics of the successful and failed episodes
Patients’ characteristics Success group (N = 317) Failure group (N = 73) P value
Age (months) 6.6 (1.6–30) 5.8 (1.4–14.7) 0.015
Males (%) 59.4 56.2 0.612
Weight (kg) 7 (4.4–13) 6 (3.5–10) 0.036
Deaths 6 (1.9 %) 9 (12.3 %) \0.001
PRISM III-24 score 3 (0–4) 5.5 (1–9) \0.001
HR (beats/min) 161 (140–180) 155 (143–172) 0.471
RR (breaths/min) 49 (37–62) 43 (30.2–55) 0.071
FiO2 (%) 40 (28–75) 50 (30–72) 0.304
SpO2 96 (93–99) 97 (93–99) 0.065
Venous PCO2 (mmHg) 53.9 (44.4–64.2) 59.5 (49.2–74) 0.040
SF ratio 270 (153.7–372.8) 208.5 (162.3–329.1) 0.170
Venous pH 7.31 (7.25–7.37) 7.3 (7.25–7.34) 0.926
Venous lactate 1.7 (1.2–2.4) 1.4 (1.1–3.1) 0.756
NIV duration (hours) 60 (33–91) 13 (4–32.5) \0.001
Data are expressed as median (interquartile range), or percentage. P values refer to the differences between NIV success and failure
groups. PRISM III-24 was calculated within the first day of PICU admission
Table 3 Predictive models of NIV outcomes. No predictive model could be calculated for episodes failing after 24 h upon NIV initiation
AUC (CI 95 %) Cutoff value
(Sn - Sp)
PPV
(CI 95 %)
NPV
(CI 95 %)
Whole sample
-0.059 9 SF ratio at 1 h (10 units) - 0.030
9 age (months) ? 0.208 9 PRISM III-24
0.755 (0.661-0.849) -1.310 (86.2-57.8) 26.9 % (17.3–36.4) 95.9 % (89.8–98.9)
Episodes failing before 6 h
SF ratio at 1 h 0.748 (0.588-0.908) 193 (77.8-70) 10.9 % (2.5–19.4) 98.5 % (94.6–99.8)
Episodes failing between 6 and 24 h
0.202 9 PRISM III-24 - 0.074 9 RR decrease
at 6 h – 0.008 9 SF ratio at 6 h (10 units)
0.895 (0.800-0.990) -0.8 (87.5-83) 31.8 % (16.9–46.7) 98.5 % (94.9–99.8)
AUC area under the curve, CI confidence interval, Sn sensitivity (in %), Sp specificity (in %), PPV positive predictive value, NPV negative
predictive value, PRISM pediatric risk of mortality
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deaths among ARDS episodes in our study (5/10),
underlines the great severity of this type of patients.
An important variable included in two of the sug-
gested predictive models was PRISM III-24 score
(Table 3). Higher values in mortality prediction models
were described as NIV failure predictors in several pre-
vious studies [4, 6, 13, 14]. It seems reasonable that the
most severe patients are those at greater risk of NIV
failure, and thus, this factor should be taken into account
when treating a child with NIV. Nevertheless, it is
important to note that we analyzed PRISM III-24, which
includes the most abnormal values from the first 24 h of
PICU stay [23], and that the score may worsen after
intubation. This should be taken into account when using
this predictive model. However, it should be highlighted
that in our study, the highest PRISM III-24 values usually
occurred before initiating invasive ventilation. It should
also be noted that severity scores that include arterial gas
analysis may lose some information as it may not be
performed to all patients. Some authors suggest the use of
noninvasive surrogates such as SF ratio, to improve the
clinical and research utility of the severity scales that
include PF ratio [25, 26].
Age was identified as another important factor in NIV
outcome, included in the general predictive model
(Table 3). This confirms the findings of previous studies,
which reported a higher failure rate in younger patients [2,
9, 12], and is consistent with the frequent difficulties to
achieve patient-ventilator synchrony in infants and small
children during two levels of pressure NIV. Leaks [27]
and inability to cycle off the ventilator due to their lack of
strength are the main practical issues. It has been sug-
gested that triggering and cycling off could be improved
if neural diaphragmatic activity sensors were employed
during NIV [28–30]. Regarding our data, with a median
age of 6.6 months (Table 1), a lot of these patients could
potentially benefit from such an advance, but additional
trials are needed to confirm or refute this speculation.
RR decrease at 6 h was also included in the predictive
model of episodes failing between 6 and 24 h. This figure
had already been related with NIV outcome in previous
studies [4, 6, 8]. The increased work of breathing is
relieved by NIV support in those cases with a good
evolution, and thus, RR decrease represents this respira-
tory improvement. It should be underlined that, despite
providing information about NIV progression at 6 h,
which may seem to be ‘‘late’’, almost two-thirds of the
failures took place after 6 h from NIV initiation. This may
help to highlight the need for continuous re-evaluation of
patients on NIV, and not only during the very first hours.
Our study has several limitations. First, some SF ratio
values could not be calculated due to high SpO2 (over
97 %). We compared these episodes of lost values with
those included in the statistical analysis and found no
statistically significant difference. Second, NIV skills may
vary from one PICU to another and also among physi-
cians. However, we consider this bias to be minimal
because initial NIV management was based on a pre-
established common protocol and the majority of the
participating PICUs have passed the standardized prac-
tical course on invasive and non-invasive mechanical
ventilation promoted and run by the Spanish Pediatric
Respiratory Group [31, 32]. Furthermore, the predictive
model is intended to be of help to physicians with dif-
ferent skills in NIV. Third, we could not analyse PCO2 in
the multivariate analysis due to the lack of values.
However, despite having been described as an outcome
predictor in some previous studies [4], its determination
usually requires repeated punctures. Invasive techniques
produce crying and patient-ventilator asynchrony, which
may contribute to NIV failure, limiting its utility in NIV.
Transcutaneous PCO2 might be useful as a surrogate of
PaCO2. Fourth, different pulse oximeters were used,
which may reduce the reproducibility of the results.
However, previous studies analyzing the correlation of SF
and PF ratios also used different types of pulse oximeters
[18]. Fifth, some other factors may alter SpO2–PaO2
correlation: PCO2 , pH, temperature and 2,3-diphospho-
glycerate. These were not taken into account to calculate
SF ratio, but previous studies suggest that the clinical
importance of these variations may be of minor signifi-
cance [18]. Mean airways pressure may also have an
effect on SpO2 and PaO2 correlation, but this was not
measured for obvious reasons.
Fig. 2 Kaplan–Meier curve showing the probability of avoiding
intubation during the first 72 h, based on the NIV failure predictive
model calculated for the whole sample, which includes SF ratio
at 1 h, age and PRISM III-24 (see Table 3). The solid line
represents the NIV episodes considered of low risk of intubation
(score B-1.310 in this predictive model), while the dashed line
represents the NIV episodes considered of high risk of intubation
(score C -1.310 in this predictive model)
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On the other hand, our study has several strengths.
First, it is the biggest study focusing on clinical predictive
factors of NIV failure in critically ill children. Second, it
is a multicenter prospective study in Spanish and Portu-
guese PICUs, which allows the findings to be
representative for both countries.
In summary, a non-invasive measurement like the SF
ratio seems to be a very useful predictive marker of the
short-term outcome in children receiving an NIV trial.
The described predictive models of outcome for different
periods after NIV initiation could help physicians make
clinical decisions whether to continue with NIV or switch
to invasive ventilation. It would be of great interest if
future research showed the utility of SF ratio as a NIV
outcome predictor in the main different causes of ARF in
children.
Acknowledgments Authors would like to thank all residents and
PICU nurse and medical staff for their invaluable support. Also
thanks to Paul Harris and Wee Tan for their style corrections.
References
1. Thia LP, McKenzie SA, Blyth TP,
Minasian CC, Kozlowska WJ, Carr SB
(2008) Randomised controlled trial of
nasal continuous positive airways
pressure (CPAP) in bronchiolitis. Arch
Dis Child 93:45–47
2. Yanez LJ, Yunge M, Emilfork M,
Lapadula M, Alca´ntara A, Ferna´ndez C,
Lozano J, Contreras M, Conto L,
Arevalo C, Gayan A, Herna´ndez F,
Pedraza M, Feddersen M, Bejares M,
Morales M, Mallea F, Glasinovic M,
Cavada G (2008) A prospective,
randomized, controlled trial of
noninvasive ventilation in pediatric
acute respiratory failure. Pediatr Crit
Care Med 9:484–489
3. Carrillo A, Gonzalez-Diaz G, Ferrer M,
Martinez-Quintana ME, Lopez-
Martinez A, Llamas N, Alcazar M,
Torres A (2012) Non-invasive
ventilation in community-acquired
pneumonia and severe acute respiratory
failure. Intensive Care Med 38:458–466
4. Essouri S, Chevret L, Durand P, Haas
V, Fauroux B, Devictor D (2006)
Noninvasive positive pressure
ventilation: five years of experience in a
pediatric intensive care unit. Pediatr
Crit Care Med 7:329–334
5. Bernet V, Hug MI, Frey B (2005)
Predictive factors for the success of
noninvasive mask ventilation in infants
and children with acute respiratory
failure. Pediatr Crit Care Med
6:660–664
6. Mayordomo-Colunga J, Medina A, Rey
C, Dı´az JJ, Concha A, Los Arcos M,
Mene´ndez S (2009) Predictive factors
of non invasive ventilation failure in
critically ill children: a prospective
epidemiological study. Intensive Care
Med 35:527–536
7. Piastra M, De LD, Marzano L, Stival E,
Genovese O, Pietrini D, Conti G (2011)
The number of failing organs predicts
non-invasive ventilation failure in
children with ALI/ARDS. Intensive
Care Med 37:1510–1516
8. James CS, Hallewell CP, James DP,
Wade A, Mok QQ (2011) Predicting the
success of non-invasive ventilation in
preventing intubation and re-intubation
in the paediatric intensive care unit.
Intensive Care Med 37(12):1994–2001
9. Joshi G, Tobias JD (2007) A five-year
experience with the use of BiPAP in a
pediatric intensive care unit population.
J Intensive Care Med 22:38–43
10. Dohna-Schwake C, Stehling F,
Tschiedel E, Wallot M, Mellies U
(2011) Non-invasive ventilation on a
pediatric intensive care unit: feasibility,
efficacy, and predictors of success.
Pediatr Pulmonol 46:1114–1120
11. Ignacio Munoz-Bonet J, Flor-Macia´n
EM, Brines J, Rosello´-Millet PM, Cruz
Llopis M, Lo´pez-Prats JL, Castillo S
(2010) Predictive factors for the
outcome of noninvasive ventilation in
pediatric acute respiratory failure.
Pediatr Crit Care Med 11:675–680
12. Ferrer M, Esquinas A, Leon M,
Gonzalez G, Alarcon A, Torres A
(2003) Noninvasive ventilation in
severe hypoxemic respiratory failure: a
randomized clinical trial. Am J Respir
Crit Care Med 168:1438–1444
13. Antonelli M, Conti G, Moro ML,
Esquinas A, Gonzalez-Diaz G,
Confalonieri M, Pelaia P, Principi T,
Gregoretti C, Beltrame F, Pennisi MA,
Arcangeli A, Proietti R, Passariello M,
Meduri GU (2001) Predictors of failure
of noninvasive positive pressure
ventilation in patients with acute
hypoxemic respiratory failure: a multi-
center study. Intensive Care Med
27:1718–1728
14. Antonelli M, Conti G, Esquinas A,
Montini L, Maggiore SM, Bello G,
Rocco M, Maviglia R, Pennisi MA,
Gonzalez-Diaz G, Meduri GU (2007) A
multiple-center survey on the use in
clinical practice of noninvasive
ventilation as a first-line intervention
for acute respiratory distress syndrome.
Crit Care Med 35:18–25
15. Rana S, Jenad H, Gay PC, Buck CF,
Hubmayr RD, Gajic O (2006) Failure of
non-invasive ventilation in patients with
acute lung injury: observational cohort
study. Crit Care 10:R79
16. Khemani RG, Patel NR, Bart RD III,
Newth CJ (2009) Comparison of the
pulse oximetric saturation/fraction of
inspired oxygen ratio and the PaO2/
fraction of inspired oxygen ratio in
children. Chest 135:662–668
17. Rice TW, Wheeler AP, Bernard GR,
Hayden DL, Schoenfeld DA, Ware LB
(2007) Comparison of the SpO2/FIO2
ratio and the PaO2/FIO2 ratio in
patients with acute lung injury or
ARDS. Chest 132:410–417
18. Khemani RG, Thomas NJ,
Venkatachalam V, Scimeme JP, Berutti
T, Schneider JB, Ross PA, Willson DF,
Hall MW, Newth CJ (2012) Pediatric
Acute Lung Injury and Sepsis Network
Investigators (PALISI) Comparison of
SpO2 to PaO2 based markers of lung
disease severity for children with acute
lung injury. Crit Care Med
40:1309–1316
19. Spada C, Gandhi R, Patel SR, Nuccio P,
Weinhouse GL, Lee PS (2011) Oxygen
saturation/fraction of inspired oxygen
ratio is a simple predictor of
noninvasive positive pressure
ventilation failure in critically ill
patients. J Crit Care 26:510–516
20. Martinon-Torres F, Rodriguez-Nunez
A, Martinon-Sanchez JM (2006) Nasal
continuous positive airway pressure
with heliox in infants with acute
bronchiolitis. Respir Med
100:1458–1462
21. Goldstein B, Giroir B, Randolph A;
International Consensus Conference on
Pediatric Sepsis (2005) International
pediatric sepsis consensus conference:
definitions for sepsis and organ
dysfunction in pediatrics. Pediatr Crit
Care Med 6:2–8
1102
22. Pons OM, Cambra Lasaosa FJ (2003)
Mechanical ventilation in pediatrics
(III). Weaning, complications and other
types of ventilation. Noninvasive
ventilation. An Pediatr (Barc)
59:165–172
23. Pollack MM, Patel KM, Ruttimann UE
(1996) PRISM III: an updated Pediatric
Risk of Mortality score. Crit Care Med
24:743–752
24. Cosentini R, Brambilla AM, Aliberti S,
Bignamini A, Nava S, Maffei A,
Martinotti R, Tarsia P, Monzani V,
Pelosi P (2010) Helmet continuous
positive airway pressure vs oxygen
therapy to improve oxygenation in
community-acquired pneumonia: a
randomized, controlled trial. Chest
138:114–120
25. Leteurtre S, Dupre´ M, Dorkenoo A,
Lampin ME, Leclerc F (2011)
Assessment of the Pediatric Index of
Mortality 2 with the Pao2/Fio2 ratio
derived from the Spo2/Fio2 ratio: a
prospective pilot study in a French
pediatric intensive care unit. Pediatr
Crit Care Med 12:e184–e186
26. Pandharipande PP, Shintani AK,
Hagerman HE, St Jacques PJ, Rice TW,
Sanders NW, Ware LB, Bernard GR,
Ely EW (2009) Derivation and
validation of Spo2/Fio2 ratio to impute
for Pao2/Fio2 ratio in the respiratory
component of the Sequential Organ
Failure Assessment score. Crit Care
Med 37:1317–1321
27. Borel JC, Sabil A, Janssens JP, Couteau
M, Boulon L, Le´vy P, Pe´pin JL (2009)
Intentional leaks in industrial masks
have a significant impact on efficacy of
bilevel noninvasive ventilation: a bench
test study. Chest 135:669–677
28. Moerer O, Beck J, Brander L, Costa R,
Quintel M, Slutsky AS, Brunet F,
Sinderby C (2008) Subject-ventilator
synchrony during neural versus
pneumatically triggered non-invasive
helmet ventilation. Intensive Care Med
34:1615–1623
29. Liet JM, Dejode JM, Joram N, Gaillard-
Le Roux B, Be´tre´mieux P, Roze´ JC
(2011) Respiratory support by neurally
adjusted ventilatory assist (NAVA) in
severe RSV-related bronchiolitis: a case
series report. BMC Pediatr 11:92
30. Clement KC, Thurman TL, Holt SJ,
Heulitt MJ (2011) Neurally triggered
breaths reduce trigger delay and
improve ventilator response times in
ventilated infants with bronchiolitis.
Intensive Care Med 37:1826–1832
31. Lopez YM, Pilar FJ, Medina JA, Lo´pez-
Herce J, Pons M, Balcells J, Martino´n-
Torres F, Modesto V, Garcı´a JA (2007)
Courses on mechanical ventilation in
pediatrics: first experience in Spain.
Pediatr Pulmonol 42:1072–1077
32. Medina A, Pons M, Martino´n-Torres F
(2009) Non-invasive ventilation in
pediatrics, 2nd edn. Ergon, Madrid
1103
